e-Article
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations
Document Type
Journal
Author
Ades, Lionel; Duployez, Nicolas; Guerci-Bresler, Agnes; Laribi, Kamel; Peterlin, Pierre; Vey, Norbert; Thepot, Sylvain; Wickenhauser, Stefan; Zerazhi, Hacene; Stamatoullas, Aspassia; Wattel, Eric; Recher, Christian; Toma, Andrea; Dimicoli-Salazar, Sophie; Braun, Thorsten; Beyne-Rauzy, Odile; Marolleau, Jean-Pierre; Cheze, Stephane; Park, Sophie; Cluzeau, Thomas; Nimubona, Stanislas; Bordessoule, Dominique; Benramdane, Riad; Quesnel, Bruno; Ame, Shanti; de Botton, Stephane; Chermat, Fathia; Preudhomme, Claude; Chevret, Sylvie; Fenaux, Pierre
Source
Subject
Language
English
ISSN
13652141